Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostacyclin Synthesis Inhibition
- Molecular classification
- Pathway, Lipid Metabolism
01
Overview
Prostacyclin (PGI₂) is a potent vasodilator and inhibitor of platelet aggregation. Inhibition of prostacyclin synthesis refers to any process or intervention that reduces or blocks the production of PGI₂. This can occur through inhibition of cyclooxygenases (COX) by NSAIDs, interference with arachidonic acid release, or direct inhibition of prostacyclin synthase. Inhibiting prostacyclin synthesis may lead to increased risk for thrombosis and enhanced vasoconstriction.
02
Mechanism of action
Inhibition of cyclooxygenases (COX-1 and COX-2), Interference with arachidonic acid release, Inhibition of prostacyclin synthase
03
Biological functions
Regulation of vasodilationRegulation of platelet aggregationInflammation modulation
04
Disease associations
ThrombosisHypertensionCardiovascular disease
05
Safety considerations
Increased risk of thrombosisEnhanced vasoconstrictionPotential for hypertension
06
Interacting drugs
NSAIDs (e.g., ibuprofen)
5 more in the full profile.
07
Biomarkers
Urinary metabolites of prostacyclin
Beyond the preview
Go deeper on Prostacyclin Synthesis Inhibition.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prostacyclin Synthesis Inhibition.